Human papillomavirus and urological tumours: II. Role in bladder, prostate, renal and testicular cancer

BJU International

Volumn 85, Issue 2, 2000, Pages 211-217

  Griffiths, T R L ^a   Mellon, J K ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

BLADDER CANCER; CANCER RISK; CELL DIFFERENTIATION; HISTOLOGY; HUMAN; IMMUNOCOMPETENCE; KIDNEY CANCER; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SQUAMOUS CELL; TESTIS CANCER; TUMOR SUPPRESSOR GENE; VIRUS INFECTION; WART VIRUS;

CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENES, P53; HUMANS; IMMUNOCOMPETENCE; KIDNEY NEOPLASMS; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROSTATIC NEOPLASMS; TESTICULAR NEOPLASMS; TUMOR VIRUS INFECTIONS; URINARY BLADDER NEOPLASMS; UROLOGIC NEOPLASMS;

EID: 0033955029     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2000.00465.x     Document Type: Review

References (67)

1. 1 Griffiths TRL, Mellon JK. Human papillomavirus and urological tumours: I. Basic science and role in penile cancer. BJU Int 1999; 84 (Suppl): 579-586
2. 2 Campo MS, Jarrett WF, Barron R, O'Neil BW, Smith KT. Association of bovine papillomavirus type 2 and bracken fern with bladder cancer in cattle. Cancer Res 1992; 52: 6898-904
3. 3 Del Mistro A, Koss LG, Braunstein J. Bennett B, Saccomano G, Simons KM. Condylomata acuminata of the urinary bladder. Natural history, viral typing and DNA content. Am J Surg Path 1988; 12: 205-15
4. 4 Aynaud O, Tranbaloc P, Orth G. Lack of evidence for a role of human papillomaviruses in transitional cell carcinoma of the bladder. J Urol 1998; 159: 86-90
5. 5 Knowles MA. Human papillomavirus sequences are not detectable by Southern blotting or general primer-mediated polymerase chain reaction in transitional cell tumours of the bladder. Urol Res 1992; 20: 297-301
6. 6 Chetsanga C, Malmstrom P-U, Gyllensten U, Moreno-Lopez J. Dinter Z, Pettersson U. Low incidence of human papillomavirus type 16 DNA in bladder tumour detected by the polymerase chain reaction. Cancer 1992; 69: 1208-11
7. 7 Tekin MI, Tuncer S, Aki FT, Bilen CY, Aygun C. Ozen H. Human papillomavirus associated with bladder carcinoma? Analysis by polymerase chain reaction, Int J Urol 1999; 6: 184-6
8. 8 Gazzaniga P, Vercillo R, Gradilone A et al. Prevalence of papillomavirus, Epstein-Barr virus, cytomegalovirus, and herpes simplex virus type 2 in urinary bladder cancer. J Med Virol 1998; 55: 262-7
9. 9 Rotola A, Monini P, Di Luca D et al. Presence and physical state of HPV DNA in prostate and urinary-tract tissues. Int J Cancer 1992; 52: 359-65
10. 10 Chang F, Lipponen P, Tervahauta A, Syrjanen S, Syrjanen K. Transitional cell carcinoma of the bladder: Failure to demonstrate human papillomavirus deoxyribonucleic acid by in situ hybridisation and polymerase chain reaction. J Urol 1994; 152: 1429-33
11. 11 Maloney KE, Wiener JS. Walther PJ. Oncogenic human papillomaviruses are rarely associated with squamous cell carcinoma of the bladder: Evaluation by differential polymerase chain reaction. J Urol 1994; 154: 360-4
12. 12 Saltzstein DR, Orihucla E, Kocurek JN, Payne DA, Chan T-S, Tyring SK. Failure of the polymerase chain reaction (PCR) to detect human papilloma virus (HPV) in transitional cell carcinoma of the bladder. Anticancer Res 1993; 13: 423-6
13. 13 Sano T, Sakurai S, Fukuda T, Nakajima T. Unsuccessful effort to detect human papillomavirus DNA in urinary bladder cancers by the polymerase chain reaction and in situ hybridisation. Pathol Int 1995; 45: 506-12
14. 14 Sinclair AL, Nouri AM, Oliver RT, Sexton C, Dalgleish AG. Bladder and prostate cancer screening for human papillomavirus by polymerase chain reaction: conflicting results using different annealing temperatures. Br J Biochem Sci 1993; 50: 350-4
15. 15 Noel JC. Thiry L, Verhest A et al. Transitional cell carcinoma of the bladder: Evaluation of the role of human papillomaviruses. Urology 1994; 44: 671-5
16. 16 Mvula M, Iwasaka T, Iguchi A, Nakamura S, Masaki Z, Sugimori H. Do human papillomaviruses have a role in the pathogenesis of bladder carcinoma? J Urol 1996; 155:471-4
17. 17 Lopez-Beltran Munoz E. Transitional cell carcinoma of the bladder: low incidence of human papillomavirus DNA detected by the polymerase chain reaction and in situ hybridisation. Histopathology 1995; 26: 565-9
18. 18 Gopalkrishna V, Srivastava AN, Hedau S, Sharma JK, Das BC. Detection of human papillomavirus DNA sequences in cancer of the urinary bladder by in situ hybridisation and polymerase chain reaction. Genitourin Med 1995; 71: 231-3
19. 19 Ludwig M, Kochel HG, Fischer C, Ringert R-H, Weidner W. Human papillomavirus in tissue of bladder and bladder carcinoma specimens. Eur Urol 1996; 30: 96-102
20. 20 Chan KW, Wong KY, Srivastava G. Prevalence of six types of human papillomavirus in inverted papilloma and papillary transitional cell carcinoma of the bladder: an evaluation by polymerase chain reaction. J Clin Pathol 1997; 50: 1018-21
21. 21 Tenti P, Zappatore R, Romagnoli S et al. p53 overexpression and human papillomavirus infection in transitional cell carcinoma of the urinary bladder: correlation with histological parameters. J Pathol 1996; 78: 65-70
22. 22 Smetana Z, Keller T, Leventon-Kriss S et al. Presence of human papilloma virus in transitional cell carcinoma in Jewish population in Israel. Cell Mol Biol 1995; 41: 1017-23
23. 23 Agliano AM, Gradilone A, Gazzaniga P et al. High frequency of human papillomavirus detection in urinary bladder cancer. Urol Int 1994; 53: 125-9
24. 24 Yu ST, Wu MM, Li LM. Prevalence of human papillomaviruses 16 and 18 in transitional cell carcinoma of bladder. Chin Med J 1993; 106: 494-6
25. 25 Anwar K, Naiki H, Nakakuki K, Inuzuka M. High frequency of human papillomavirus infection in carcinoma of the urinary bladder. Cancer 1992; 70: 1967-73
26. 26 Walboomers JMM, Jacobs MV, van Oostveen JW et al. Detection of genital human papillomavirus infections and possible clinical implications. In Gross G, von Krough G, eds. Human Papillomavirus Infections in Dermatovenereology. New York: CRC Press, 1997: 341
27. 27 Cecchini S, Cipparrone I, Confortini M. Urethral cytology of cytobrush specimens. Acta Cytol 1988; 32: 314-7
28. 28 Zderic SA, Capiniello VL, Malloy TR. Urological applications of human papillomavirus typing using deoxyribonucleic acid probes for the diagnosis and treatment of genital condyloma. J Urol 1989; 141: 63-5
29. 29 Weiner JS, Liu ET, VValther PJ. Oncogenic human papillomavirus type 16 is associated with squamous cell carcinoma of the male urethra. Cancer Res 1992; 52: 5018-23
30. 30 Weiner JS, Walther PJ. Carcinomas of the female urethra are linked to human papillomavirus: polymerase chain reaction based analysis of multiple histological types. J Urol 1994; 151: 49-53
31. 31 Boucher NR, Scholefield JH, Anderson JB. The actiological significance of human papillomavirus in bladder cancer. Br J Urol 1996; 78: 866-9
32. 32 Bryant P, Davies P, Wilson D. Detection of human papillomavirus DNA in cancer of the urinary bladder by in situ hybridisation, Br J Urol 1991; 68: 49-52
33. 33 Shibutani YF, Schoenberg MP, Carpiniello VL, Malloy TR. Human papillomavirus associated with bladder cancer. Urology 1992; 40: 15-7
34. 34 Furihata M, Inoue K, Ohtsuki Y, Hashimoto H, Terao N, Fujita Y. High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder. Cancer Res 1993; 53: 4823-7
35. 35 Kamel D, Paakko P, Pollanen R, Vahakangas K, Lehto VP, Soini Y. Human papillomavirus DNA and abnormal p53 expression in carcinoma of the urinary bladder. APMIS 1995; 103: 331-8
36. 36 Kallioniemi A, Kallioniemi O-P, Citro G et al. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridisation. Genes Chromosomes Cancer 1995; 12: 213-9
37. 37 Savelieva E, Belair CD, Newton MA et al. 20q gain associates with immortalization: 20q1 3.2 amplification correlates with genome instability in human papillomavirus 16, E7 transformed human uroepithelial cells. Oncogene 1997; 14: 551-60
38. 38 Fradet Y, Lafleur L, LaRue H. Strategies of chemoprevention based on antigenic and molecular markers of early and premalignant lesions of the bladder. J Cell Biochem year?; Suppl. 161: 85-92
39. 39 Syrjanen KJ. Biology of human papillomavirus (HPV) infections and their role in squamous cell carcinogenesis. Med Biol 1987; 65: 21-39
40. 40 Wilczynski SP, Oft M, Cook N, Liao SY, Iftner T. Human papillomavirus type 6 in squamous cell carcinoma of the bladder and cervix. Human Pathol 1993; 24: 96-102
41. 41 Cooper K, Haffajee Z, Taylor L. Human papillomavirus and schistosomiasis associated bladder cancer. Mol Pathol 1997; 50: 145-8
42. 42 Lu Ql EI-Nasir L, Abel P. Human papillomavirus 16 and 18 infection is absent in urinary bladder carcinomas. Eur Urol 1997; 31: 428-32
43. 43 Kerley SW, Persons DL, Fishback JL. Human papillomavirus and carcinoma of the urinary bladder. Mod Pathol 1991; 4: 316-9
44. 44 Querci della Rovere G, Oliver RT, McCance DJ. Castro JE. Development of bladder tumour containing HPV type 11 DNA after renal transplantation. Br J Urol 1988; 62: 36-8
45. 45 Key T. Risk factors for prostate cancer. Cancer Surv 1995; 23: 63-77
46. 46 Strickler HD, Burk R, Shah K et al. A multifaceted study of human papillomavirus and prostate carcinoma. Cancer 1998; 82: 1118-25
47. 47 Serth J, Panitz F, Paeslack U, Kuczyk MA, Jonas U. Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers. Cancer Res 1999; 59: 823-5
48. 48 Moyret-Lalle C, Marcais C, Jacquemier J et al. Ras. p53 and HPV status in benign and malignant prostate tumours. Int J Cancer 1995; 64: 124-9
49. 49 McNicol PJ, Dodd JG. Detection of human papillomavirus DNA in prostate gland tissue by using the polymerase chain reaction amplification assay. J Clin Microbiol 1990; 28: 409-12
50. 50 Noda T, Sasagawa T, Dong Y, Fuse H, Namiki M, Inoue M. Detection of human papillomavirus (HPV) DNA in archival specimens of benign prostatic hyperplasia and prostatic cancer using a highly sensitive nested PCR method. Urol Res 1998; 26: 165-9
51. 51 Effert PJ, Frye RA, Neubauer A, Liu ET, Walther PJ. Human papillomavirus types 16 and 18 are not involved in human prostate carcinogenesis: analysis of archival human prostate cancer specimens by differential polymerase chain reaction. J Urol 1992; 147: 192-6
52. 52 Tu H. Jacobs SC, Mergner VVJ, Kypianou N. Rare incidence of human papillomavirus types 16 and 18 in primary and metastatic human prostate cancer. Urology 1994; 44: 726-31
53. 53 Wideroff L, Schottenfeld D, Carey TE et al. Human papillomavirus DNA in malignant and hyperplastic prostate tissue of black and white males. Prostate 1996; 28: 117-23
54. 54 Sarkar FH, Sakr WA, Li YW, Sreepathi P, Crissman JD. Detection of human papillomavirus (HPV) DNA in human prostatic tissues by polymerase chain reaction (PCR). Prostate 1993; 22: 171-80
55. 55 Suzuki H, Komiya A, Aida S, lto H, Yatani R, Shimazaki J. Detection of human papillomavirus DNA and p53 gene mutations in human prostate cancer. Prostate 1996; 28: 318-24
56. 56 Terris MK, Peehl DM. Human papillomavirus detection by polymerase chain reaction in benign and malignant prostate tissue is dependent on the primer set utilized. Urology 1997; 50: 150-6
57. 57 Ibrahim GK, Gravitt PE, Dittrich KL et al. Detection of human papillomavirus in the prostate by polymerase chain reaction and in situ hybridisation. J Urol 1992; 148: 1822-6
58. 58 Anwar K, Nakakuki K, Shiraishi T, Naiki H, Yatani R, Inuzuka M. Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas. Cancer Res 1992; 52: 5991-6
59. 59 Greer CE, Peterson SL, Kiviat NB, Manos MM. PCR amplification from paraffin-embedded tissues. Effects of fixative and fixation time. Am J Clin Pathol 1991; 95: 117-24
60. 60 Dillner J, Knekt P, Boman J et al. Sero-epidemiological association between human papillomavirus infection and risk of prostate cancer. Int J Cancer 1998; 75: 564-7
61. 61 Kamel D, Turpecnnemi-Hujanen T, Vahakangas K, Paakko P, Soini Y. Proliferating cell nuclear antigen but not p53 or human papillomavirus DNA correlates with advanced clinical stage in renal cell carcinoma. Histopathology 1994; 25: 339-47
62. 62 Grce M, Furcic I, Hrascan R et al. Human papillomaviruses are not associated with renal carcinoma. Anticancer Res 1997; 17: 2193-6
63. 63 Kondoh G, Murata Y, Aozasa K, Yutsudo M, Hakura A. Very high incidence of germ cell tumorigenesis (seminomagenesis) in human papillomavirus type 16 transgenic mice. J Virol 1991; 65: 3335-9
64. 64 Kondoh G, Hayasaka N, Li Q, Nishimune Y, Hakura A. An in vivo model for receptor tyrosine kinase autocrine/ paracrine activation: auto-stimulated KIT receptor acts as a tumour promoting factor in papillomavirus-induced tumorigenesis. Oncogene 1995; 10: 341-7
65. 65 Rajpert-De Meyts E, Hording U, Nielsen HW, Skakkeback NE. Human papillomavirus and Epstein-Barr virus in the aetiology of testicular germ cell tumours. APMIS 1994; 102: 38-42
66. 66 Strickler HD, Schiffman MH, Shah KV et al. A survey of human papillomavirus 16 antibodies in patients with epithelial cancers. Eur J Cancer Prev 1998; 7: 305-13
67. 67 Alani RM, Munger K. Human papillomaviruses and associated malignancies. J Clin Oncol 1998; 16: 330-7